Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation
AssigneeNeoGenesis Pharmaceuticals, Inc.
InventorKrishna Kalghatgi
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeoGenesis Pharmaceuticals, Inc.
InventorKrishna Kalghatgi
Estimating the term…
The present invention provides a method for producing a mass-coded combinatorial library comprising a set of compounds having the general formula X(Y)n, where X is a scaffold, each Y is, independently, a peripheral moiety, and n is an integer greater than 1. The method comprises selecting a peripheral moiety precursor subset from a peripheral moiety precursor set. The subset includes a sufficient number of peripheral moiety precursors that at least about 50 distinct combinations of n peripheral moieties derived from the peripheral moiety precursors in the subset exist. The subset of peripheral moiety precursors is selected so that at least about 90% of all possible combinations of n peripheral moieties derived from the subset have a molecular mass sum which is distinct from the molecular mass sums of all of the other combinations of n peripheral moieties. The method further comprises contacting the peripheral moiety precursor subset with a scaffold precursor which has n reactive groups. Methods of use of the mass-coded combinatorial library produced by this method for identifying a ligand to a particular biomolecule are also disclosed.
A method for identifying a member of a mass-coded molecular library which is a ligand for a first biomolecule but is not a ligand for a second biomolecule, said method comprising the steps of:
Dependencies are inferred from the claim text.